Sex-based differences in autoimmune diseases

Annali dell'Istituto Superiore di Sanita

Volumn 52, Issue 2, 2016, Pages 205-212

  Ortona, Elena ^a   Pierdominici, Marina ^a   Maseli, Angela ^b   Veroni, Caterina ^a   Aloisi, Francesca ^a   Shoenfeld, Yehuda ^c  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b Instituto Superiore di Sanitei   (Italy)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

Autoimmunity; Multiple sclerosis; Rheumatoid arthritis; Sex; Systemic lupus erythematosus

Indexed keywords

SEX HORMONE;

AUTOIMMUNE DISEASES; FEMALE; GENETICS; HUMAN; MALE; MICROBIOLOGY; MICROFLORA; PATHOPHYSIOLOGY; SEX DIFFERENCE; SEXUAL DEVELOPMENT;

AUTOIMMUNE DISEASES; FEMALE; GONADAL STEROID HORMONES; HUMANS; MALE; MICROBIOTA; SEX CHARACTERISTICS; SEX FACTORS;

EID: 84979879897     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: 10.4415/ANN_16_02_12     Document Type: Article

References (78)

1. Quintcro OL, Amador-Patarroyo MJ, Montoya-Ortiz G, Rojas-Villarraga A, Anaya JM. Autoimmune disease and gender: Plausible mechanisms for the female predominance of autoimmunity J Autoimmun 2012;38(2-3):J109- J19. DOI:10.1016/j.jaut.2011.10.003.
2. Shapira Y, Agmon-Levin N, Shocnfeld Y. Defining and analyzing geocpidemiology and human autoimmunity. J Autoimmun 2010;34(3):J168-J177. DOI:10.1016/j.jaut.2009.11.018.
3. Zandman-Goddard G, Pccva E, Shocnfeld Y. Gender and autoimmunity. Autoimmun Rev 2007;6(6):366-72. DOI:10.1016/j.autrcv.2006.10.001.
4. Bauer M, Glenn T, Pilhatsch M, Pfennig A, Whybrow PC. Gender differences in thyroid system function: Relevance to bipolar disorder and its treatment. Bipolar Disord 2014;16(1):58-71. DOI:10.1111/bdi.12150.
5. Rubtsova K, Marrack P, Rubtsov AV. Sexual dimorphism in autoimmunity. J Clin Invest 2015;125(6):2187-93. DOI:10.1172/JC178082.
6. Borchers AT, Gershwin ME. Sociological differences between women and men: implications for autoimmunity. Autoimmun Rev 2012;11(6-7):A413-A421. DOI:10.1016/j.autrcv.2011.11.016.
7. Pierdominici M, Maselli A, Colasanti T, Giammarioli AM, Dclunardo F, Vacirca D, Sanchez M, Giovannctti A, Malorni W, Ortona E. Estrogen receptor profiles in human peripheral blood lymphocytes. Immunol Lett 2010; 132(1-2):79-85. DOI:10.1016/j.imlct.2010.06.003.
8. Neill JD. Knobil and Neill's physiology of reproduction. Third Edition. New York: Academic Press; 2005.
9. Straub RH. The complex role of estrogens in inflammation. Endocr Rev 2007;28(5):521-74. DOI:10.1210/er.2007-0001.
10. Pricto GA, Roscnstcin Y. Ocstradiol potentiates the suppressive function of human CD4 CD25 regulatory T cells by promoting their proliferation. Immunology 2006;118(1):58-65. DOI:10.111l/j.1365-2567.2006.02339.x.
11. Shelly S, Boaz M, Orbach H. Prolactin and autoimmunity. Autoimmun Rev 2012;11(6-7):A465-A470. DOI:10.1016/j.autrcv.2011.11.009.
12. Tan IJ, Peeva E, Zandman-Goddard G. Hormonal modulation of the immune system - A spotlight on the role of progestogens. Autoimmun Rev 2015;14(6):536-42. DOI:10.1016/j.autrcv.2015.02.004.
13. Trigunaitc A, Dimo J, Jorgcnsen TN. Suppressive effects of androgens on the immune system. Cell Immunol 2015;294(2):87-94. DOI:10.1016/j.ccllimm.2015.02.004.
14. Borchers AT, Naguwa SM, Keen CL, Gershwin ME. The implications of autoimmunity and pregnancy J Autoimmun 2010;34(3):J287-J299DOI:10.1016/j.jaut.2009.11.015.
15. Kanda N, Tsuchida T, Tamaki K. Estrogen enhancement of anti-double- stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum 1999;42(2):328-37. DOI10.1002/1529-0131(199902)42:2<328::AID-ANR16>3, O.CO;2-.
16. Selmi C, Brunctta E, Raimondo MG, Mcroni PL. The X chromosome and the sex ratio of autoimmunity. Autoimmun Rev 2012;11(6-7):A531-A537. DOI:10.1016/j.autrcv.2011.11.024.
17. Jorgcnscn KT, Rostgaard K, Bachc I, Biggar RJ, Nielsen NM, Tommcrup N, Frisch M. Autoimmune diseases in women with Turner's syndrome. Arthritis Rheum 2010;62(3):658-66. DOI:10.1002/art.27270.
18. Seminog OO, Scminog AB, Ycatcs D, Goldacrc MJ. Associations between Klincfcltcr's syndrome and autoimmune diseases: English national record linkage studies. Autoimmunity 2015;48(2):125-8. DOI:10.3109/08916934.2014.968918.
19. Murphy ED, Roths J B. AY chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoprolifcration. Arthritis Rheum 1979;22( 11 ):1188- 94. DOI:10.1002/art.1780221105.
20. Singh RP, Massachi I, Manickavcl S, Singh S, Rao NP, Hasan S, Mc Curdy DK, Sharma S, Wong D, Hahn BH, Rchimi H. The role of miRNA in inflammation and autoimmunity. Autoimmun Rev 2013; 12( 12): 1160-5. DOI:10.1016/j.autrcv.2013.07.003.
21. Ghorai A, Ghosh U. miRNA gene counts in chromosomes vary widely in a species and biogenesis of miRNA largely depends on transcription or post- Transcriptional processing of coding genes. Front Genet 2014;5( 100): 1- 11. DOI:10.3389/fgcnc.2014.00100.
22. Khan D, Dai R, Ansar Ahmed S. Sex differences and estrogen regulation of miRNAs in lupus, a prototypical autoimmune disease. Cell Immunol 2015;294(2):70-9. DOI:10.1016/j.ccllimm.2015.01.004.
23. Pinhciro I, Dcjager L, Libert C. X-chromosomc-locatcd microRNAs in immunity: might they explain male/female differences? The X chromosomc-gcnomic context may affect X-locatcd miRNAs and downstream signaling, thereby contributing to the enhanced immune response of females. Bioessays 2011;33(11):791-802. DOI:10.1002/bics.201100047.
24. Klinge CM. Estrogen regulation of MicroRNA expression. Curr Genomics 2009; 10(3): 169-83. DOI:10.2174/138920209788185289.
25. Gomez A, Luckcy D, Taneja V. The gut microbiomc in autoimmunity: Sex matters. Clin Immunol 2015;159(2):154- 62. DOI:10.1016/j.clim.2015.04.016.
26. Marklc JG, Frank DN, Mortin-Toth S, Robertson CE, Fcazcl LM, Rollc-Kampczyk U, von Bergen M, McCoy KD, Macphcrson AJ, Danska JS. Sex differences in the gut microbiomc drive hormone-dependent regulation of autoimmunity. Science 2013;339(6123):1084-8. DOI:10.1126/science.1233521.
27. Yurkovctskiy L, Burrows M, Khan AA, Graham L, Volch- kov P, Becker L, Antonopoulos D, Umcsaki Y, Chervonsky AV. Gender bias in autoimmunity is influenced by mi- crobiota. Immunity 2013;39(2):400-12. DOI:10.1016/j.immuni.2013.08.013.
28. Kosicwiez MM, Drydcn GW, Chhabra A, Alard P. Relationship between gut microbiota and development of T cell associated disease. FEBS Lett 2014;588(22):4195- 206. DOI:10.1016/j.fcbslct.2014.03.019.
29. Gomez A, Luckey D, Yeoman CJ, Marietta EV, Berg Miller ME, Murray J A, White BA, Tancja V. Loss of sex and age driven differences in the gut microbiomc characterize arthritis-susceptible 0401 mice but not arthritis- resistant 0402 mice. PLoS One 2012;7(4):e36095. DOI:10.1371/journal.pone.0036095.
30. Ngo ST, Stcyn FJ, McCombc PA. Gender differences in autoimmune disease. Front Neuroendocrinal 2014;35(3):347-69DOI:10.1016/j.yfrnc.2014.04.004.
31. Chighizola C, Mcroni PL. The role of environmental estrogens and autoimmunity. Autoimmun Rev 2012; 11(6- 7):A493-A501. DOI:10.1016/j.autrcv.2011.11.027.
32. Borchers AT, Naguwa SM, Shoenfeld Y, Gershwin ME. The geocpidemiology of systemic lupus erythematosus. Autoimmun Rev 2010;9(5):A277-A287. DOI:10.1016/j.au- Trcv.2009.12.008.
33. Gualtierotti R, Biggioggcro M, Pcnatti AE, Meroni PL. Updating on the pathogenesis of systemic lupus erythematosus. Autoimmun Rev2010;10(1):3-7. DOI:10.1016/j.autrev.2010.09.007.
34. Pierdominici M, Ortona E. Estrogen Impact on Autoimmunity Onset and Progression: The Paradigm of Systemic Lupus Erythematosus. International Trends in Immunity 2013;1 (2):24-34.
35. Roubinian J, Talal N, Siitcri PK, Sadakian JA. Sex hormone modulation of autoimmunity in NZB/NZW mice. Arthritis Rheum 1979;22(11): 1162-9. DOI:10.1002/art.1780221102.
36. Li J, McMurray RW. Effects of estrogen receptor sub- Typc-sclcctivc agonists on autoimmune disease in lu- pus-prone NZB/NZW F1 mouse model. Clin Immunol 2007; 123(2):219-26. DOI:10.1016/j.clim.2007.01.008.
37. Svenson JL, EuDaly J, Ruiz P, Korach KS, Gilkcson GS. Impact of estrogen receptor deficiency on disease expression in the NZM2410 lupus prone mouse. Clin Immunol 2008; 128(2):259-68. DOI:10.1016/j.clim.2008.03.508.
38. Cutolo M, Capcllino S, Sulli A, Scrioli B, Sccchi ME, Vil- laggio B, Straub RH. Estrogens and autoimmune diseases. Ann N Y Acad Sci 2006;1089:538-47. DOI:10.1196/annals.1386.043.
39. Colasanti T, Masclli A, Conti F, Sanchez M, Alessandri C, Barbati C, Vacirca D, Tinari A, Chiarotti F, Giovan- netti A, Franconi F, Valcsini G, Malorni W, Picrdominici M, Ortona E. Autoantibodies to estrogen receptor alpha interfere with T lymphocyte homeostasis and arc associated with disease activity in systemic lupus erythematosus. Arthritis Rheum 2012;64(3):778-87. DOI:10.1002/art.33400.
40. Latecf A, Petri M. Hormone replacement and contraceptive therapy in autoimmune diseases. J Autoimmun 2012;38(2-3):J170-J176. DOI:10.1016/j.jaut.2011.11.002.
41. Abdou NI, Rider V, Greenwell C, Li X, Kimler BF. Ful- vestrant (Faslodex), an estrogen selective receptor down- regulator, in therapy of women with systcmic lupus erythematosus. clinical, serologic, bone density, and T cell activation marker studies: A double-blind placcbo-con- Trollcd trial. J Rheumatol 2008;35(5):797.
42. Dai R, Ahmed SA. MicroRNA, a new paradigm for understanding immunorcgulation, inflammation, and autoimmune diseases. Transl Res 2011; 157(4): 163-79. DOI:10.1016/j.trsl.2011.01.007.
43. Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y, Huang X, Zhou H. de Vries N. Tak PP. Chen S. Shen N. MicroR NA- 146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 2009;60(4): 1065-75DOI:10.1002/art.24436.
44. Zhao X, Tang Y, Qu B, Cui H, Wang S, Wang L, Luo X, Huang X, Li J, Chen S, Shen N. MicroRNA-125a contributes to elevated inflammatory chcmokinc RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum 2010;62(11):3425-35. DOI:10.1002/art.27632.
45. Pan W, Zhu S, Yuan M, Cui H, Wang L, Luo X, Li J, Zhou H, Tang Y, Shen N. MicroRNA-21 and microR- NA-148a contribute to DNA hypomcthylation in lupus CD4+ T cclls by directly and indirectly targeting DNA mcthyltransferase 1. J Immunol 2010;184(12):6773-81. DOI:10.4049/jimmunol.0904060.
46. Dai R, Phillips RA, Zhang Y, Khan D, Crasta O, Ahmed SA. Suppression of LPS-induced Interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen- regulated microRNAs: A novel mechanism of immune modulation. Bood 2008;112(12):4591-7. DOI:10.1182/blood-2008-04-152488.
47. Lu LJ, Wallace DJ, Ishimori ML, Scofield RH, Weis- man MH. Review: Male systemic lupus erythematosus: A review of sex disparities in this disease. Lupus 2010;19(2):119-29. DOI:10.1177/0961203309350755.
48. Murphy G, Iscnberg D. Effect of gender on clinical presentation in systemize lupus erythematosus. Rheumatology (Oxford) 2013;52(12):2108-15. DOI:10.1093/rhcuma- Tology/kctl60.
49. Tobon GJ, Youinou P, Saraux A. The environment, geocpidemiology, and autoimmune disease: Rheumatoid arthritis. J Autoimmun 2010;35(1):10-4. DOI:10.1016/j.jaut.2009.12.009.
50. Hughes GC, Choubcy D. Modulation of autoimmune rheumatic diseases by oestrogen and progesterone. Nat Rev Rheumatol 2014;10(12):740-51. DOI:10.1038/nrrhcum.2014.144.
51. Sokka T, Toloza S, Cutolo M, Kautiaincn H, Makinen H, Gogus F, Skakic V, Badsha H. Pccts T, Baranauskaitc A, Gchcr P, Ujfalussy I, Skopouli FN, Mavrommati M, Altcn R, Pohl C, Sibilia J, Stancati A, Salaffi F, Romanowski W, Zarowny-Wicrzbinska D, Hcnrohn D, Brcsnihan B, Min- nock P, Knudscn LS, Jacobs JW, Calvo-Alcn J, Lazovskis J, Pinhciro Gda R, Karatecv D, Andcrsonc D, Rcxhcpi S, Yazici Y, Pincus T. Women, men, and rheumatoid arthritis: Analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther 2009;11(1):R7. DOI:10.1186/ar2591.
52. Castagnetta LA, Carruba G, Granata OM, Stefano R, Micle M, Schmidt M, Cutolo M, Straub RH. Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis. J Rheumatol 2003;30( 12):2597-605.
53. Ostcnsen M, Villiger PM. The remission of rheumatoid arthritis during pregnancy. Semin Immunopathol 2007;29(2): 185-91. DOI:10.1007/s00281-007-0072-5.
54. Inoue K, Inouc E, Imai Y. Female sex hormones ameliorate arthritis in SKG mice. Biochetn Biophys Res Commun 2013;434(4 ):740-5. DOI:10.1016/j.bbrc.2013.03.111.
55. Zoli A, Ferlisi EM, Lizzio M, Altomontc L, Mironc L, Barini A, Scuderi F, Bartolozzi F, Magaro M. Prolac- Tin/cortisol ratio in rheumatoid arthritis. Ann N Y Acad Sci 2002;966:508-12. DOI:10.1111/j.1749-6632.2002.tb04255.x.
56. Wilder RL. Adrenal and gonadal steroid hormone deficiency in the pathogenesis of rheumatoid arthritis. J Rheumatol Suppl 1996:44:10-2.
57. Cutolo M. Androgens in rheumatoid arthritis: When arc they effectors? Arthritis Res Ther 2009; 11(5): 126. DOI:10.1186/ar2804.
58. Jawaheer D, Olsen J, Hetland ML. Sex differences in response to anti- Tumor necrosis factor therapy in early and established rheumatoid arthritis - results from the DAN BIO registry. J Rheumatol 2012;39(1):46-53. DOI:10.3899/jrhcum.110548.
59. Cutolo M. Sex hormone adjuvant therapy in rheumatoid arthritis. Rheum Dis Clin North Am 2000;26(4):881-95. DOI:10.1016/S0889-857X(05)70174-5.
60. van den Brink HR, van Everdingen AA, van Wijk MJ, Jacobs J W, Bijlsma JW. Adjuvant oestrogen therapy docs not improve disease activity in postmenopausal patients with rheumatoid arthritis. Ann Rheum Dis 1993;52(12):862-5. DOI:doi:10.1136/ard.52.12.862.
61. Stark K, Straub RH, Rovcnsky J, Blazickova S, Eisclt G, Schmidt M. CYB5A polymorphism increases androgens and reduces risk of rheumatoid arthritis in women. Arthritis Res Ther 2015;17:56. DOI:10.1186/s13075-015-0574-9.
62. Burkhardt J, Pctit-Tcixcira E, Tcixcira VH, Kirstcn H, Gamier S, Ruchlc S, Ocscr C, Wolfram G, Scholz M, Migliorini P, Balsa A, Wcsthovcns R, Barrcra P, Alvcs H, Pascual-Salccdo D, Bombardicri S, Dcquckcr J, Rad- stakc TR, Van Ricl P, van de Puttc L, Bardin T, Prum B, Buchcggcr-Podbiclski U, Emmrich F, Mclchcrs I, Cornc- lis F, Ahncrt P. Association of the X-chromosomal genes TIMP1 and IL9R with rheumatoid arthritis. J Rheumatol 2009;36(10):2149-57. DOI:10.3899/jrhcum.090059.
63. Ribbons KA, McElduff P, Boz C, Trojano M, Izquicrdo G, Duquette P, Girard M, Grand'Maison F, uppcrts R, Grammond P, Orcja-Gucvara C, Petersen T, Bcrgamaschi R, Giuliani G, Barnctt M, van Pcsch V, Amato MP, Iuliano G, Fiol M, Slec M, Vcrhcul F, Cristiano E, Fcrnandcz-Bolanos R, Saladino ML, Rio ME, Cabrera- Gomez J, Butzkucvcn H, van Munstcr E, Den Brabcr- Mocrland L, La Spitalcri D, Lugarcsi A, Shayganncjad V, Gray O, Deri N, Alroughani R, Lechner-Scott J. Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS. PLoS One 2015; 10(6):c0122686. DOI:10.1371/journal, pone.0122686.
64. Trojano M, Lucchcsc G, Graziano G, Taylor BV, Simpson S Jr., Leporc V, Grand'maison F, Duquette P, Izquicrdo G, Grammond P, Amato MP, Bcrgamaschi R, Giuliani G, Boz C, Huppcrts R, Van Pcsch V, Lechncr-Scott J, Cristiano E, Fiol M, Orcja-Gucvara C, Saladino ML, Vcrhcul F, Slec M, Paolicclli D, Tortorclla C, D'Onghia M, Iaffaldano P, Dircnzo V, Butzkucvcn H. Geographical variations in sex ratio trends over time in multiple sclerosis. Plos One 2012;7( 10):c48078. DOI:10.1371/journal.pone.0048078.
65. Gourraud PA, Harbo HF, Hauscr SL, Baranzini SE. The genetics of multiple sclerosis: An up- To-date review. Immunol Kev 2012:248(1 ):87-103. DOI:10.1111/j.1600-065X.2012.01134.x.
66. Sawcer S, Franklin RJ, Ban M. Multiple sclerosis genetics. Lancet Neurol 2014;13(7):700-9. DOI:10.1016/S1474-4422(14)70041-9.
67. Bove R, Chitnis T. The role of gender and sex hor mones in determining the onset and outcome of multiple sclerosis. Mult Scler 2014;20(5):520-6. DOI:10.1177/1352458513519181.
68. Pozzilli C, Pugliatti M. An overview of pregnancy-related issues in patients with multiple sclerosis. Eur J Neurol 2015;22(Suppl. 2):34-9. DOI:10.1111/cnc.l2797.
69. Gilli F, Lindberg RL, Valentino P, Marnctto F, Maluc-chi S, Sala A, Capobianco M, di Sapio A, Sperli F, Kap- pos L, Calogcro RA, Bcrtolotto A. Learning from nature: Pregnancy changes the expression of inflammation-re- latcd genes in patients with multiple sclerosis. Plos One 2010;5(1):c8962. DOI:10.1371/journal.ponc.0008962.
70. Voskuhl RR, Gold SM. Sex-related factors in multiple sclerosis susceptibility and progression. Nat Rev Neurol 2012;8(5):255-63. DOI:10.1038/nrncurol.2012.43.
71. Bove R, Musallam A, Hcaly BC, Raghavan K, Glanz BI, Bakshi R, Weiner H, De Jager PL, Miller KK, Chitnis T. Low testosterone is associated with disability in men with multiple sclerosis. Mult Scler 2014:20(12): 1584-92. DOI:10.1177/1352458514527864.
72. Kurth F, Ludcrs E, Sicotte NL, Gascr C, Giesscr BS, Swerdloff RS, Montag MJ, Voskuhl RR, Mackenzie- Graham A. Neuroprotective effects of testosterone treatment in men with multiple sclerosis. Neuroimage Clin 2014;4:454-60. DOI:10.1016/j.nicl.2014.03.001.
73. Voskuhl RR, Wang H, Wu TC, Sicotte NL, Nakamura K, Kurth F, Itoh N, Bardcns J, Bernard JT, Corboy JR, Cross AH, Dhib-Jalbut S, Ford CC, Frohman EM, Giesscr B, Jacobs D, Kaspcr LH, Lynch S, Parry G, Rackc MK, Re- dcr AT, Rose J, Wingcrchuk DM, MacKcnzic-Graham AJ, Arnold DL, Tseng CH, Elashoff R. Estriol combined with glatiramer acetate for women with relapsing-remit- Ting multiple sclerosis: A randomised, placebo-controlled, phase 2 trial. Lancet Neurol 2016;15(1):35-46. DOI:10.1016/S1474-4422(15)00322-1.
74. Aschcrio A. Munger KL, Luncmann JD. The initiation and prevention of multiple sclerosis. Nat Rev Neurol 2012;8(11):602-12. DOI:10.1038/nrncurol.2012.198.
75. Ramanujam R, Hedstrom AK, Manouchchrinia A, Al- fredsson L, Olsson T, Bottai M, Hillert J. Effect of smoking cessation on multiple sclerosis prognosis. JAMA Neurol 2015;72(10):1117-23. DOI:10.1001/jamancu-rol.2015.1788.
76. Schoonheim MM, Vigcvcno RM, Rueda Lopes FC, Pouwels PJ, Polman CH, Barkhof F, Geurts JJ. Sex-specific extent and severity of white matter damage in multiple sclerosis: implications for cognitive decline. Hum Drain Mapp 2014;35(5):2348-58. DOI:10.1002/hbm.22332.
77. Irizar H, Munoz-Culla M, Scpulvcda L, Sacnz-Cucsta M, Prada A, Castillo-Trivino T, Zamora-Lopcz G, Lopez dc Munain A, Olascoaga J, Otacgui D. Transcrip- Tomic profile reveals gender-specific molecular mechanisms driving multiple sclerosis progression. Plos One 2014;9(2):c90482. DOI:10.1371/journal.ponc.0090482.
78. Veroni C, Marnetto F, Granicri L, Bcrtolotto A, Ballerini C, Repicc AM, Schirru L, Coghc G, Cocco E, Anastasi- Adou E, Puopolo M, Aloisi F. Immune and Epstein -Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cclls from patients with relapsing -remitting multiple sclerosis. J Neuro inflammation 2015:12:132. DOI:10.1186/s12974-015-0353-1.